177 related articles for article (PubMed ID: 24452210)
1. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.
Wang Z; Zhao H; Ma JX; Xu X
Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.
Zheng Y; Gu Q; Xu X
Acta Ophthalmol; 2012 Nov; 90(7):e512-23. PubMed ID: 22994140
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
Su L; Xu X; Zhao H; Gu Q; Zou H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
[TBL] [Abstract][Full Text] [Related]
4. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.
Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X
Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024
[TBL] [Abstract][Full Text] [Related]
5. H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
Sun Y; Su L; Wang Z; Xu Y; Xu X
BMC Cell Biol; 2013 Feb; 14():8. PubMed ID: 23433118
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
Su W; Li Z; Li Y; Lin M; Yao L; Liu Y; He Z; Wu C; Liang D
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9108-15. PubMed ID: 22039247
[TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic effects of integrin alpha5beta1 inhibitor (ATN-161) in vitro and in vivo.
Wang W; Wang F; Lu F; Xu S; Hu W; Huang J; Gu Q; Sun X
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7213-20. PubMed ID: 21813636
[TBL] [Abstract][Full Text] [Related]
8. A novel and effective human hepatocyte growth factor kringle 1 domain inhibits ocular neovascularization.
Lu Q; Zhang L; Shen X; Zhu Y; Zhang Q; Zhou Q; Gan R; Zhang H; Zhong Y; Xie B
Exp Eye Res; 2012 Dec; 105():15-20. PubMed ID: 23085338
[TBL] [Abstract][Full Text] [Related]
9. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.
Li C; Li L; Cheng R; Dai Z; Li C; Yao Y; Zhou T; Yang Z; Gao G; Yang X
Cornea; 2013 May; 32(5):680-8. PubMed ID: 23343948
[TBL] [Abstract][Full Text] [Related]
10. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
12. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
[No Abstract] [Full Text] [Related]
13. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Pathologic Corneal Neovascularization by Topical Application of a Novel Peptide In Vivo.
Lu Y; Xu Y; Gu Q; Xu X
Cornea; 2015 Oct; 34(10):1295-302. PubMed ID: 26266428
[TBL] [Abstract][Full Text] [Related]
15. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro.
Li F; Bai Y; Zhao M; Huang L; Li S; Li X; Chen Y
Ophthalmic Res; 2015; 53(3):109-16. PubMed ID: 25676100
[TBL] [Abstract][Full Text] [Related]
16. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of the human prothrombin kringle-2 peptide derivative NSA9: anti-proliferative activity and cellular internalization.
Hwang HS; Kim DW; Kim SS
Biochem J; 2006 Apr; 395(1):165-72. PubMed ID: 16390327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]